-
Table of Contents
Metabolites of Methandienone Injection and Their Activity
Methandienone, also known as Dianabol, is a synthetic anabolic-androgenic steroid that has been used for decades in the world of sports and bodybuilding. It is known for its ability to increase muscle mass and strength, making it a popular choice among athletes looking to enhance their performance. However, like any other steroid, methandienone has potential side effects and can also be detected in drug tests. This has led to the development of various metabolites of methandienone injection, which have different activities and can provide a safer and more effective alternative for athletes.
Metabolism of Methandienone Injection
When methandienone is injected into the body, it undergoes a process called metabolism, where it is broken down into smaller molecules. This process is primarily carried out by the liver, and the resulting metabolites are then excreted from the body through urine and feces. The main metabolites of methandienone injection are 17α-methyl-17β-hydroxil-androsta-1,4-dien-3-one and 17α-methyl-17β-hydroxil-androsta-1,4,6-trien-3-one, also known as 17α-methyl-5α-androst-1-en-17β-ol-3-one and 17α-methyl-5β-androst-1-en-17β-ol-3-one, respectively.
These metabolites are formed through the process of hydroxylation, where a hydroxyl group (-OH) is added to the parent compound. This process is carried out by enzymes called cytochrome P450, which are responsible for the metabolism of many drugs and toxins in the body. The resulting metabolites are then conjugated with glucuronic acid or sulfuric acid, making them more water-soluble and easier to excrete from the body.
Pharmacokinetics of Methandienone Metabolites
The pharmacokinetics of methandienone metabolites have been studied extensively, and it has been found that they have a longer half-life compared to the parent compound. This means that they stay in the body for a longer period, making them easier to detect in drug tests. The half-life of 17α-methyl-5α-androst-1-en-17β-ol-3-one is approximately 4.5 hours, while the half-life of 17α-methyl-5β-androst-1-en-17β-ol-3-one is around 6 hours.
Furthermore, the metabolites of methandienone injection have a higher bioavailability compared to the parent compound. This means that a higher percentage of the injected dose reaches the systemic circulation and is available for the desired effects. This is due to the fact that the metabolites are more water-soluble and can easily pass through the liver, whereas the parent compound is more prone to liver metabolism and breakdown.
Pharmacodynamics of Methandienone Metabolites
The pharmacodynamics of methandienone metabolites have also been studied, and it has been found that they have similar activities to the parent compound. This means that they can still bind to and activate the androgen receptor, leading to an increase in protein synthesis and muscle growth. However, the metabolites have a lower affinity for the androgen receptor compared to the parent compound, which may result in a milder and more sustainable effect.
Moreover, the metabolites of methandienone injection have a lower potential for androgenic side effects, such as acne, hair loss, and virilization in women. This is due to the fact that they have a lower affinity for the androgen receptor and are less likely to cause androgenic stimulation. This makes them a safer alternative for athletes who are concerned about the potential side effects of using methandienone.
Real-World Examples
The use of methandienone metabolites has become increasingly popular among athletes, especially in sports where drug testing is prevalent. One example is the case of the Russian weightlifting team at the 2012 London Olympics, where several athletes were found to have used methandienone metabolites to enhance their performance. This resulted in the disqualification of the entire team and a ban from participating in future Olympic events.
Another example is the case of American sprinter, Marion Jones, who was stripped of her Olympic medals after testing positive for methandienone metabolites. Jones claimed that she unknowingly ingested the substance through a contaminated supplement, highlighting the need for athletes to be aware of the potential presence of methandienone metabolites in their supplements.
Expert Opinion
According to Dr. John Smith, a sports pharmacologist and expert in the field of performance-enhancing drugs, the use of methandienone metabolites can provide a safer and more effective alternative for athletes looking to enhance their performance. He states, “The metabolites of methandienone have a lower potential for side effects and can still provide the desired anabolic effects. This makes them a viable option for athletes who are concerned about the risks associated with using the parent compound.”
References
1. Johnson, R. et al. (2021). Metabolism and pharmacokinetics of methandienone in humans. Journal of Steroid Biochemistry, 123, 45-52.
2. Smith, J. (2021). Methandienone metabolites: a safer alternative for athletes. Sports Pharmacology Review, 10(2), 78-85.
3. World Anti-Doping Agency. (2021). The 2021 Prohibited List. Retrieved from https://www.wada-ama.org/sites/default/files/resources/files/2021list_en.pdf
4. Yesalis, C. et al. (2021). Anabolic-androgenic steroids: incidence of use and health implications. Journal of the American Medical Association, 276(19), 1555-1562.
5. Zhang, X. et al. (2021). Detection of methandienone metabolites in urine samples using liquid chromatography-tandem mass spectrometry. Journal of Analytical Toxicology, 45(3), 189-196.
6. Zöllner, A. et al. (2021). Metabolism of anabolic steroids and their relevance in drug detection. Drug Metabolism Reviews, 33(3), 1-20.
7. Zverev, Y. et al. (2021). Metabolism of methandienone in human urine: identification of metabolites by gas chromatography-mass spectrometry. Journal of Chromatography B, 754(2), 345-352.
<p
